ReviewJournal of palliative medicine2014
Integration of palliative care in end-stage liver disease and liver transplantation.
Review in Journal of palliative medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.
- Palliative Care for Patients with End-Stage Liver Disease on the Liver Transplant Waiting List: An International Systematic Review.Digestive diseases and sciences · 2021Pooled it
- Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.Palliative medicine · 2019Pooled it
- Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.Journal of general internal medicine · 2019Trial
- Trial
- Beyond the Tipping Point: Advances in the Diagnosis and Management of Acute-on-Chronic Liver Failure and End-Stage Liver Disease.Diagnostics (Basel, Switzerland) · 2026Review
- Hepatocyte-like cell therapy for end-stage liver disease: From basic science to clinical application.Liver research (Beijing, China) · 2026Review
- Improving access to inpatient palliative care for patients with end-stage liver disease: a quality improvement project.BMJ open quality · 2025Article
- Palliative care for people with substance use disorders: a qualitative study of the experiences of rural primary care providers.BMC palliative care · 2025Article
- Palliative care in terminally ill advanced chronic liver disease patients.Wiener klinische Wochenschrift · 2025Review
- Palliative Care Referral Patterns and Outcomes for Patients with End-Stage Liver Disease at an Academic Liver Transplant Center.Journal of palliative medicine · 2025Article
- Multidimensional Experience of Pain in Adults With Cirrhosis: A Cross-sectional Survey Study.Gastro hep advances · 2025Article
- A path to recovery for overlooked populations and their unique challenges: integrating rehabilitation in palliative care for patients with substance use disorders.Frontiers in rehabilitation sciences · 2024Article
- Article
- Palliative care and end of life care in decompensated cirrhosis.Clinical liver disease · 2023Article
- A Pilot Study of a Palliative Care Service Embedded in a Hepatology Clinic at a Large Public Hospital.Journal of palliative medicine · 2023Article
- The prognostic relationship between donor age and infectious risk in liver transplant patients with nonalcoholic steatohepatitis: Analysis of UNOS database.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2023Article
- Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario.PharmacoEconomics · 2023Article
- A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States.World journal of hepatology · 2022Article
- Inventing Engineered Organoids for end-stage liver failure patients.Journal of molecular histology · 2022Review
- The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections.Infection and immunity · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with end-stage liver disease (ESLD) have a life-limiting illness that causes multiple distressing symptoms and negatively affects quality of life (QOL). This population traditionally has not had much attention within the palliative care community. DISCUSSION: This article provides an evidence-based review of palliative care issues that patients with ESLD and those awaiting liver transplant face, including approaches to prognosis, symptom management, advance care planning, and end-of-life care.
conclusionTremendous opportunity exists to integrate palliative medicine into the care of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.